BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8392475)

  • 1. [Gene TP53 and digestive cancers].
    Tominaga O; Salmon RJ; Laurent-Puig P
    Gastroenterol Clin Biol; 1993; 17(3):187-96. PubMed ID: 8392475
    [No Abstract]   [Full Text] [Related]  

  • 2. Numerical aberrations of chromosome 17 and the p53 locus in small hepatocellular carcinomas.
    Yano H; Nanashima A; Hidaka S; Haseba M; Tanaka K; Yamaguchi H; Nakagoe T; Tagawa Y; Nagayasu T
    Anticancer Res; 2004; 24(1):111-5. PubMed ID: 15015584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 17 allele loss in hepatocellular carcinoma but not in synchronous liver adenoma.
    Ding SF; Jalleh RP; Dooley J; Wood CB; Habib NA
    Eur J Surg Oncol; 1993 Apr; 19(2):195-7. PubMed ID: 8387935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer.
    Han HJ; Yanagisawa A; Kato Y; Park JG; Nakamura Y
    Cancer Res; 1993 Nov; 53(21):5087-9. PubMed ID: 8221640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
    Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
    Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in the TP53 tumor suppressor gene in malignant transformation of Barrett esophagus].
    Ferec C; Audrezet MP; Mercier B; Robaszkiewicz M
    Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D46-51. PubMed ID: 8013783
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic aberration in primary hepatocellular carcinoma: correlation between p53 gene mutation and loss-of-heterozygosity on chromosome 16q21-q23 and 9p21-p23.
    Wang G; Huang CH; Zhao Y; Cai L; Wang Y; Xiu SJ; Jiang ZW; Yang S; Zhao T; Huang W; Gu JR
    Cell Res; 2000 Dec; 10(4):311-23. PubMed ID: 11191353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic factors in families with combined gastrointestinal and breast cancer.
    Lynch HT; Krush AJ; Guirgis H
    Am J Gastroenterol; 1973 Jan; 59(1):31-40. PubMed ID: 4686470
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tumor suppressor gene, p53, and hepatocarcinogenesis].
    Masutomi K; Kaneko S; Kobayashi K
    Nihon Rinsho; 2001 Oct; 59 Suppl 6():138-41. PubMed ID: 11761930
    [No Abstract]   [Full Text] [Related]  

  • 10. [Loss of heterozygosity on chromosomes 17 and 16 in primary hepatocellular carcinomas].
    Shao J; Li X; Liu Z
    Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):428-30. PubMed ID: 11715437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome analyses of two recently established human tumour cell lines derived from a carcinoma of the oesophagus and a primary liver tumour.
    Robinson K; Bey E; Alexander JJ; Gear JH
    S Afr J Med Sci; 1976; 41(4):285-95. PubMed ID: 190714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic aberrations in human hepatocellular carcinomas of differing etiologies.
    Wong N; Lai P; Pang E; Fung LF; Sheng Z; Wong V; Wang W; Hayashi Y; Perlman E; Yuna S; Lau JW; Johnson PJ
    Clin Cancer Res; 2000 Oct; 6(10):4000-9. PubMed ID: 11051249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization.
    Kobayashi M; Kawashima A; Mai M; Ooi A
    Am J Pathol; 1996 Nov; 149(5):1575-84. PubMed ID: 8909247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of aberrations of 17p and p53 gene in gastrointestinal cancers by dual (two-color) fluorescence in situ hybridization and GeneChip p53 assay.
    Takahashi Y; Nagata T; Asai S; Shintaku K; Eguchi T; Ishii Y; Fujii M; Ishikawa K
    Cancer Genet Cytogenet; 2000 Aug; 121(1):38-43. PubMed ID: 10958939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor.
    Cheung ST; Chen X; Guan XY; Wong SY; Tai LS; Ng IO; So S; Fan ST
    Cancer Res; 2002 Aug; 62(16):4711-21. PubMed ID: 12183430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetics of colorectal cancers].
    Pocard M; Salmon RJ
    Ann Chir; 1996; 50(3):211-6. PubMed ID: 8763122
    [No Abstract]   [Full Text] [Related]  

  • 17. [Genetic changes in carcinoma of the colon].
    Lazo PA
    Med Clin (Barc); 1992 Sep; 99(9):350-4. PubMed ID: 1435007
    [No Abstract]   [Full Text] [Related]  

  • 18. [Correlation between p53 nuclear protein accumulation and mutations of the p53 gene in human esophageal cancer from linxian].
    Liang Y; Lu S; Guo Y
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):412-4. PubMed ID: 8697989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infrequent DPC4 gene mutation in esophageal cancer, gastric cancer and ulcerative colitis-associated neoplasms.
    Lei J; Zou TT; Shi YQ; Zhou X; Smolinski KN; Yin J; Souza RF; Appel R; Wang S; Cymes K; Chan O; Abraham JM; Harpaz N; Meltzer SJ
    Oncogene; 1996 Dec; 13(11):2459-62. PubMed ID: 8957088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic aspects of gastrointestinal cancer.
    McConnell RB
    Clin Gastroenterol; 1976 Sep; 5(3):483-503. PubMed ID: 1022371
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.